General Archive
-
News releasesPromising results in clinical trial gives hope to patients with blood disorder
A trial for a cutting-edge cell therapy that could become the first ever treatment for the rare, life-threatening blood disorder…
-
News releases3 steps LifeArc is taking to tackle antimicrobial resistance before it’s too late
Antimicrobial resistance (AMR) is one of the most urgent public health challenges of our time, threatening not only human health…
-
News releases£76M investment backing into potential MND treatment, underlines benefit of charity funding
Promising new research to develop gene therapy to treat motor neuron disease and other conditions like dementia secures big investment…
-
News releasesTackling antimicrobial resistance: LifeArc partners with the University of Cape Town to launch a new Centre for Translational AMR Research
LifeArc has announced a significant £5 million investment to co-establish a new Centre for Translational AMR Research (CTAR) Programme at…
-
News releasesLifeArc joins public involvement pledge to improve health research
LifeArc has joined the Shared Commitment to Public Involvement, alongside more than 25 other leading health and research organisations such…
-
News releasesNewborn screening programme a big step forward for rare disease research
The announcement by Genomics England and NHS England on the newborn sequencing programme is a significant step forward in transforming…
-
News releasesLifeArc launches UK’s first cystic fibrosis Innovation Hub Network
The UK’s first network of Cystic Fibrosis Lung Health Innovation Hubs is being launched to accelerate the development of new…
-
News releasesDr Sam Barrell CBE joins LifeArc as new CEO
We are excited to welcome Dr Sam Barrell, CBE, as she officially joins the LifeArc team today as our new…
-
News releasesGlobal AMR challenge receives a £5m boost to drive diagnostics innovation
PACE (Pathways to Antimicrobial Clinical Efficacy) has launched its second funding round with up to £5 million available to support…
-
News releasesLifeArc becomes founding partner of new Fleming Initiative to tackle global threat of antimicrobial resistance
LifeArc has joined the Fleming Initiative as a founding partner alongside Cepheid and Optum, contributing to the initiative reaching a…
-
News releasesFirst awardees of £3m collaborative Drug Discovery Programme are announced
The Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate has announced the first cohort of awardees of its Collaborative Discovery Programme…
-
News releasesCharities join forces to transform treatment for children with cancer
A pioneering initiative to develop new medicines exclusively for children’s and young people’s cancers, has been launched LifeArc and Cancer…